Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Australian Blue Quandong (Santalum acuminatum) contains polyphenolic compounds at approximately 90 mg GAE/g dry weight that provide antioxidant capacity through free radical scavenging mechanisms. In vitro studies demonstrate strong correlations with DPPH (R²=0.9855), CUPRAC (R²=0.9944), and FRAP (R²=0.9899) antioxidant assays.
Reported Benefits (Provisional)
Origin & History
Australian Blue Quandong (Elaeocarpus angustifolius) is a fruit tree native to the rainforests of northern Queensland, Australia. It is now cultivated in tropical and subtropical regions worldwide. This vibrant, plum-like fruit is recognized for its tart flavor and nutritional density.
Research Narrative (Provisional)
Scientific studies are emerging to validate the traditional uses of Australian Blue Quandong, focusing on its high antioxidant content and potential benefits for digestive, immune, and skin health. Further clinical research is needed to fully characterize its bioactive compounds and therapeutic efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamin C - Dietary Fiber - Flavonoids - Antioxidants
Reported Mechanism (Provisional)
Polyphenolic compounds in Blue Quandong provide antioxidant capacity primarily through free radical scavenging mechanisms, as demonstrated by strong correlations in DPPH, CUPRAC, and FRAP assays. The phenolic content of approximately 90 mg GAE/g dry weight drives these protective effects by neutralizing reactive oxygen species and reducing oxidative cellular damage. While broader Australian native fruits show potential anti-inflammatory and antimicrobial pathways from phenolics, specific enzyme inhibition mechanisms for Blue Quandong remain uncharacterized.
Clinical Narrative (Provisional)
Clinical evidence for Australian Blue Quandong is extremely limited, with no published human or animal clinical trials identified in current literature. Available research consists solely of in vitro antioxidant capacity testing using standard assays like CUPRAC, FRAP, and DPPH methods. While preclinical research on Australian native fruits suggests potential anticancer and anti-inflammatory properties, quantified clinical data specifically for Blue Quandong is absent. Further rigorous clinical research is essential to validate traditional uses and establish therapeutic efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.